O-12 NCI9673 (Part B): A multi-institutional ETCTN randomized phase II study of nivolumab with or without ipilimumab in refractory, metastatic squamous cell carcinoma of the anal canalVan K. Morris, Cathy Eng, John C. Krauss et al.|Annals of Oncology|2023Cited by 9
Clinical, pathological, and adjuvant chemotherapy use differences among microsatellite unstable and microsatellite stable colon cancersBaqir Jafry, Syed Mohammad Ali Kazmi, Munir H. Buhaya et al.|Journal of the National Cancer Center|2024Cited by 5